6-1611567-G-GGGC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001453.3(FOXC1):c.1139_1141dupGCG(p.Gly380dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.204 in 1,139,916 control chromosomes in the GnomAD database, including 26,099 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.22 ( 4474 hom., cov: 24)
Exomes 𝑓: 0.20 ( 21625 hom. )
Consequence
FOXC1
NM_001453.3 disruptive_inframe_insertion
NM_001453.3 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.420
Genes affected
FOXC1 (HGNC:3800): (forkhead box C1) This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it has been shown to play a role in the regulation of embryonic and ocular development. Mutations in this gene cause various glaucoma phenotypes including primary congenital glaucoma, autosomal dominant iridogoniodysgenesis anomaly, and Axenfeld-Rieger anomaly. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 6-1611567-G-GGGC is Benign according to our data. Variant chr6-1611567-G-GGGC is described in ClinVar as [Benign]. Clinvar id is 193213.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.649 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXC1 | NM_001453.3 | c.1139_1141dupGCG | p.Gly380dup | disruptive_inframe_insertion | 1/1 | ENST00000645831.2 | NP_001444.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXC1 | ENST00000645831.2 | c.1139_1141dupGCG | p.Gly380dup | disruptive_inframe_insertion | 1/1 | NM_001453.3 | ENSP00000493906.1 |
Frequencies
GnomAD3 genomes AF: 0.223 AC: 32657AN: 146364Hom.: 4481 Cov.: 24
GnomAD3 genomes
AF:
AC:
32657
AN:
146364
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0483 AC: 655AN: 13566Hom.: 83 AF XY: 0.0519 AC XY: 461AN XY: 8876
GnomAD3 exomes
AF:
AC:
655
AN:
13566
Hom.:
AF XY:
AC XY:
461
AN XY:
8876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.202 AC: 200308AN: 993452Hom.: 21625 Cov.: 32 AF XY: 0.199 AC XY: 94319AN XY: 474342
GnomAD4 exome
AF:
AC:
200308
AN:
993452
Hom.:
Cov.:
32
AF XY:
AC XY:
94319
AN XY:
474342
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.223 AC: 32661AN: 146464Hom.: 4474 Cov.: 24 AF XY: 0.232 AC XY: 16535AN XY: 71288
GnomAD4 genome
AF:
AC:
32661
AN:
146464
Hom.:
Cov.:
24
AF XY:
AC XY:
16535
AN XY:
71288
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 09, 2014 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 02, 2018 | - - |
Axenfeld-Rieger syndrome type 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at